Table of contents
1. Introduction
1.1 Definition
1.2 Scope of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3. Market dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market factor analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power of Suppliers
4.3 Bargaining Power of Buyers
4.4 Threat of New Entrants
4.5 Threat of Substitutes
4.6 Intensity of Rivalry
5. Global Polyps Market, by Stage
5.1 Introduction
5.2 Benign Polyp
5.3 Pre-Malignant Polyp
6. Global Polyps Market, by Types
6.1 Introduction
6.2 Digestive Polyps
6.3 Endometrial Polyp
6.4 Cervical Polyp
6.5 Nasal Polyps
6.6 Laryngeal Polyps
6.6 Others
7. Global Polyps Market, by Diagnosis
7.1 Introduction
7.2 Occult Blood and Stool Test
7.3 Colonoscopy
7.4 Sigmoidoscopy
7.5 Double Contrast Barium Enema
7.7 Computed Tomography
7.7 Others
8. Global Polyps Market, by Treatment
8.1 Introduction
8.2 Drugs
8.2.1 Hormonal Drugs
8.2.2 Pain Killers
8.2.3 Others
8.3 Surgery
8.3.1 Polypectomy
8.3.2 Minimally Invasive Surgery
8.3.3 Colon and Rectum Removal
8.3.4 Others
9. Global Polyps Market, by End Users
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Academic and Research
9.4 Others
10. Global Polyps Market, by Region
10.1 North America
10.1.1 Introduction
10.2 Europe
10.2.1 Introduction
10.3 Asia Pacific
10.3.1 Introduction
10.4 Middle East & Africa
10.4.1 Introduction
11. Competitive landscape
11.1 Major Strategies Adopted by Market Players
11.1.1 Strategic Partnership
11.1.2 Merger & Acquisition
12. Company profile
12.1 Millennium Surgical Corp,
12.1.1 Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.2 Black Smith Surgical
12.2.1 Overview
12.2.2 Product Overview
12.2.3 Financials
12.2.4 Key Developments
12.3 B. Braun Melsungen AG,
12.3.1 Overview
12.3.2 Product Overview
12.3.3 Financials
12.3.4 Key Development
12.4 Medtronic
12.4.1 Overview
12.4.2 Product Overview
12.4.3 Financials
12.4.3 Key Development
12.5 Endo Pharmaceuticals Inc.,
12.5.1 Overview
12.5.2 Product Overview
12.5.3 Financials
12.5.3 Key Development
12.6 Cook Medical
12.6.1 Overview
12.6.2 Product Overview
12.6.3 Financials
12.6.3 Key Development
12.7 Pfizer Inc.
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.3 Key Development
12.8 Teva Pharmaceutical Industries Ltd.
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.3 Key Development
12.9 Novartis AG
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.3 Key Development
12.10 Sun Pharmaceuticals
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.3 Key Development
12.11 Mylan Inc.
12.11.1 Overview
12.11.2 Product Overview
12.11.3 Financials
12.11.3 Key Development
12.12 Others
13. Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of The Market
13.2 Key Companies to Watch
13.3 Prediction of Polyps Industry
14. Appendix
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
